Guidance Document Information
| Title |
Guidelines for the Use of Isoniazid/Rifapentine for Treatment of Latent TB Infection in Health Department Settings |
| Document ID |
EPI-411 |
| Summary |
Provides guidance on the use of the isoniazid/rifapentine regimen for the treatment of latent tuberculosis infection. (Last review 12/2015) |
| Effective Date |
10/1/2012 |
View document text
Posted On 12/30/2015
Document on Town Hall
|
| Explanation or Citations |
Based on guidance from Centers for Disease Control and Prevention. Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection. MMWR 2011;60:1650-1653. http://www.cdc.gov/mmwr/pdf/wk/mmy6048.pdf |
This document applies to the following chapters
Back to showing guidance documents for this board
Back to showing guidance documents for this agency
